5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 5 most undervalued biotech stocks to buy according to hedge funds.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | RA Capital Management Peter Kolchinsky | 4,417,259 | $48,368,986 | 0.75% | |
2. | BioImpact Capital Mpm Capital | 1,745,943 | $19,118,076 | 4.47% | |
3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,259,476 | $13,791,262 | 0.34% | |
4. | Citadel Investment Group Ken Griffin | 1,129,788 | $12,371,179 | +13% | 0% |
5. | EcoR1 Capital Oleg Nodelman | 1,115,022 | $12,209,491 | 0.31% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$8.37 | 5,000 | Officer | 19,429 | 2023-10-12 | Filing | |
$32.85 | 20,000 | Director | 3,192,058 | 2022-03-23 | Filing | |
$33.43 | 5,000 | Director | 3,172,058 | 2022-03-22 | Filing | |
$33.09 | 3,700 | Director | 3,167,058 | 2022-03-22 | Filing | |
$31.88 | 21,300 | Director | 3,163,358 | 2022-03-22 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$16.87 | 219,638 | 1,804,058 | 2023-08-23 | Filing | ||
$15.63 | 95,516 | 2,023,696 | 2023-08-23 | Filing | ||
$14.19 | 34,846 | 2,119,212 | 2023-08-23 | Filing | ||
$19.51 | 1,171 | Director | 0 | 2022-06-09 | Filing | |
$19.86 | 10,577 | Director | 0 | 2022-06-08 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 4,261,745 | $46,666,108 | 0% | |
2. | 2,738,785 | $29,989,696 | 14.73% | |
3. | 1,804,058 | $19,754,435 | 0.98% | |
4. | 1,490,942 | $16,325,815 | 0% | |
5. | 1,131,493 | $12,389,849 | 0% |